Gluteus Maximus Transfer for Hip Abductor Insufficiency Following Total Hip Arthroplasty
Clinical and Functional Outcomes of Gluteus Maximus Transfer for the Management of Hip Abductor Insufficiency Following Total Hip Arthroplasty: A Clinical Study
Hip abductor insufficiency is a challenging complication following total hip arthroplasty (THA). It may result from damage to the abductor muscles or tendons, particularly the gluteus medius and minimus, and can lead to persistent hip pain, muscle weakness, a positive Trendelenburg sign, and impaired walking ability.
Gluteus maximus transfer is a surgical procedure used to restore the function of the hip abductor mechanism in patients with severe abductor insufficiency. This study aims to evaluate the clinical and functional outcomes of gluteus maximus transfer in patients who develop abductor insufficiency following total hip arthroplasty.
The study will assess postoperative improvements in hip function, abductor strength, gait, pain, and patient-reported functional outcomes, as well as the occurrence of postoperative complications. The hypothesis is that gluteus maximus transfer can provide meaningful functional improvement in appropriately selected patients with persistent abductor insufficiency following total hip arthroplasty.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
**Inclusion Criteria**
- Adult patients aged 18 years or older.
- Patients who underwent primary or revision total hip arthroplasty.
- Patients with symptomatic hip abductor insufficiency following total hip arthroplasty.
- Clinical evidence of abductor mechanism deficiency, including abductor weakness, positive Trendelenburg sign, or gait disturbance.
- Patients with irreparable or functionally deficient hip abductor mechanism considered suitable for gluteus maximus transfer.
- Availability of preoperative and postoperative clinical and functional assessment data.
**Exclusion Criteria**
- Active periprosthetic joint infection at the time of the planned procedure.
- Neurological disorders significantly affecting hip abductor function or gait.
- Severe gluteus maximus muscle dysfunction or insufficiency that precludes transfer.
- Severe medical comorbidities contraindicating surgery.
- Inadequate clinical follow-up or missing essential outcome data.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Gluteus Maximus Transfer
Patients with hip abductor insufficiency following total hip arthroplasty undergoing gluteus maximus transfer for reconstruction of the deficient hip abductor mechanism. |
Surgical transfer of the gluteus maximus muscle to reconstruct the deficient hip abductor mechanism in patients with persistent abductor insufficiency following total hip arthroplasty. The procedure aims to improve hip abductor function, pelvic stability, gait, and overall functional outcomes. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Hip Abductor Muscle Strength
大体时间:Preoperative assessment and 12 months postoperatively.
|
Assessment of hip abductor muscle strength before and after gluteus maximus transfer using manual muscle testing according to the Medical Research Council (MRC) grading scale (0-5). |
Preoperative assessment and 12 months postoperatively.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Functional Outcome - Harris Hip Score
大体时间:preoperative baseline to 12 months postoperatively
|
Change in Harris Hip Score from preoperative baseline to 12 months postoperatively to assess hip pain and function. |
preoperative baseline to 12 months postoperatively
|
|
Trendelenburg Sign
大体时间:preoperative and 12 month postoperative
|
Assessment of the presence or absence of Trendelenburg sign during clinical examination before and 12 month after surgery. |
preoperative and 12 month postoperative
|
|
Pain Assessment
大体时间:preoperative and 12 months postoperative
|
Change in hip pain intensity measured using the Visual Analog Scale (VAS). |
preoperative and 12 months postoperative
|
|
Postoperative Complications
大体时间:during the period of follow up 12 months postoperative
|
Documentation of postoperative complications, including persistent abductor weakness, infection, dislocation, wound complications, and revision surgery. |
during the period of follow up 12 months postoperative
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- asy453789
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.